Related Experiment Video
Updated: Jan 31, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV
R Bijker1, A Jiamsakul1, E Uy2
1The Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Insights
Cardiovascular disease (CVD) is a growing concern in aging HIV-positive populations. Key risk factors include older age, high blood pressure, cholesterol, triglycerides, and BMI, highlighting the need for targeted interventions in HIV care.
Area of Science:
- Infectious Diseases
- Cardiology
- Public Health
Background:
- The aging HIV-positive population presents unique health challenges, with cardiovascular disease (CVD) emerging as a significant contributor to morbidity and mortality.
- Understanding CVD risk factors in this demographic is crucial for effective clinical management and public health strategies.
Purpose of the Study:
- To investigate the causes of death (CODs) in a multi-country Asian HIV-positive cohort, with a specific focus on CVD-related deaths.
- To identify factors associated with the development of fatal and nonfatal CVD events in individuals living with HIV.
Main Methods:
- Utilized data from the Therapeutics, Research, Education and AIDS Training in Asia (TREAT Asia) HIV Observational Database (TAHOD) from 2003-2017.
- Included patients on antiretroviral therapy (ART) with over one day of follow-up, analyzing cumulative incidences of various CODs and CVD events.
- Employed competing risk regression to assess risk factors for any CVD event.
Main Results:
- Out of 8069 patients, 378 deaths occurred, including 22 CVD-related deaths.
- Significant risk factors for CVD events included older age (≥51 years), high blood pressure, high total cholesterol, high triglycerides, and high body mass index (BMI).
- Crude incidence rates for CVD events were lower in later ART initiation periods and in middle-income countries.
Conclusions:
- Fatal and nonfatal CVD events in the HIV-positive cohort were associated with older age and modifiable risk factors like hypertension, dyslipidemia, and obesity.
- Lower CVD event rates in middle-income countries might suggest under-diagnosis in resource-limited Asian-Pacific settings, warranting further investigation.
Objectives:
With aging of the HIV-positive population, cardiovascular disease (CVD) increasingly contributes to morbidity and mortality. We investigated CVD-related and other causes of death (CODs) and factors associated with CVD in a multi-country Asian HIV-positive cohort.
Methods:
Patient data from 2003-2017 were obtained from the Therapeutics, Research, Education and AIDS Training in Asia (TREAT Asia) HIV Observational Database (TAHOD). We included patients on antiretroviral therapy (ART) with > 1 day of follow-up. Cumulative incidences were plotted for CVD-related, AIDS-related, non-AIDS-related, and unknown CODs, and any CVD (i.e. fatal and nonfatal). Competing risk regression was used to assess risk factors of any CVD.
Results:
Of 8069 patients with a median follow-up of 7.3 years [interquartile range (IQR) 4.4-10.7 years], 378 patients died [incidence rate (IR) 6.2 per 1000 person-years (PY)], and this total included 22 CVD-related deaths (IR 0.36 per 1000 PY). Factors significantly associated with any CVD event (IR 2.2 per 1000 PY) were older age [sub-hazard ratio (sHR) 2.21; 95% confidence interval (CI) 1.36-3.58 for age 41-50 years; sHR 5.52; 95% CI 3.43-8.91 for ≥ 51 years, compared with < 40 years], high blood pressure (sHR 1.62; 95% CI 1.04-2.52), high total cholesterol (sHR 1.89; 95% CI 1.27-2.82), high triglycerides (sHR 1.55; 95% CI 1.02-2.37) and high body mass index (BMI) (sHR 1.66; 95% CI 1.12-2.46). CVD crude IRs were lower in the later ART initiation period and in lower middle- and upper middle-income countries.
Conclusions:
The development of fatal and nonfatal CVD events in our cohort was associated with older age, and treatable risk factors such as high blood pressure, triglycerides, total cholesterol and BMI. Lower CVD event rates in middle-income countries may indicate under-diagnosis of CVD in Asian-Pacific resource-limited settings.
More Related Videos
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Assessment of the Cardiovascular System II: Inspection
Head and Neck
Assessment of the Cardiovascular System IV: Auscultation
Normal Heart Sounds
S1 (First Heart Sound)-
S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
S2 (Second Heart Sound)-
S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.